UNLABELLED: We describe an 11-year-old girl who initially had mild hepatosplenomegaly and then presented with abnormal expansion of CD3-negative granular lymphocytes in peripheral blood and Epstein-Barr virus (EBV) genome in the DNA obtained from the peripheral blood mononuclear cells (PBMNC). After approximately 3 years, she developed oedema, ascites, marked hepatosplenomegaly, and pancytopenia, and showed both a profile of anti-EBV antibodies of reactivated infection and a high titre of anti-cytomegalovirus antibody. Although she was treated with antibiotics, ganciclovir, and prednisolone, she died of hepatic failure. CONCLUSION: Careful clinical observation, periodic examination of anti-EBV antibodies, and the analysis of EBV genome from PBMNC are needed in young patients with CD3-negative lymphoproliferative disease of granular lymphocytes.
UNLABELLED: We describe an 11-year-old girl who initially had mild hepatosplenomegaly and then presented with abnormal expansion of CD3-negative granular lymphocytes in peripheral blood and Epstein-Barr virus (EBV) genome in the DNA obtained from the peripheral blood mononuclear cells (PBMNC). After approximately 3 years, she developed oedema, ascites, marked hepatosplenomegaly, and pancytopenia, and showed both a profile of anti-EBV antibodies of reactivated infection and a high titre of anti-cytomegalovirus antibody. Although she was treated with antibiotics, ganciclovir, and prednisolone, she died of hepatic failure. CONCLUSION: Careful clinical observation, periodic examination of anti-EBV antibodies, and the analysis of EBV genome from PBMNC are needed in young patients with CD3-negative lymphoproliferative disease of granular lymphocytes.
Authors: Y Ohno; R Amakawa; S Fukuhara; C R Huang; H Kamesaki; H Amano; T Imanaka; Y Takahashi; Y Arita; T Uchiyama Journal: Cancer Date: 1989-07-01 Impact factor: 6.860
Authors: F R Aronson; R A Dempsey; M Allegretta; J André-Schwartz; P A Poldre; C D Hillyer; D R Parkinson; R A Rudders; R S Schwartz; J W Mier Journal: Am J Hematol Date: 1987-08 Impact factor: 10.047
Authors: J Hara; K Yumura-Yagi; S Tagawa; S Ishihara; A Tawa; T Ninomiya; H Wakiguchi; C Shimazaki; T Kitani; K Kawa-Ha Journal: Leukemia Date: 1990-08 Impact factor: 11.528
Authors: K Kawa-Ha; S Ishihara; T Ninomiya; K Yumura-Yagi; J Hara; F Murayama; A Tawa; K Hirai Journal: J Clin Invest Date: 1989-07 Impact factor: 14.808
Authors: G Semenzato; F Pandolfi; T Chisesi; G De Rossi; G Pizzolo; R Zambello; L Trentin; C Agostini; E Dini; M Vespignani Journal: Cancer Date: 1987-12-15 Impact factor: 6.860
Authors: K Oshimi; O Yamada; T Kaneko; S Nishinarita; Y Iizuka; A Urabe; T Inamori; S Asano; S Takahashi; M Hattori Journal: Leukemia Date: 1993-06 Impact factor: 11.528